5-78781863-G-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000046.5(ARSB):c.1325C>G(p.Thr442Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000046.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSB | NM_000046.5 | c.1325C>G | p.Thr442Arg | missense_variant | Exon 7 of 8 | ENST00000264914.10 | NP_000037.2 | |
ARSB | XM_011543390.2 | c.1325C>G | p.Thr442Arg | missense_variant | Exon 8 of 9 | XP_011541692.1 | ||
ARSB | XR_001742066.3 | n.*50C>G | downstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461774Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727192
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 6 Pathogenic:3
Variant summary: ARSB c.1325C>G (p.Thr442Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. A different variant, c.1325C>T (p.Thr442Met) has been reported as pathogenic/likely pathogenic, supporting the critical relevance of the Thr442 residue to ARSB protein function. The variant was absent in 251396 control chromosomes. c.1325C>G has been reported in the literature in at-least one individual affected with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome) (example Karageorgos_2007). At least one publication reports experimental evidence evaluating an impact on protein function (Karageorgos_2007). The most pronounced variant effect results in <3% of normal activity in the fibroblast cell line from a patient with this variant in compound heterozygosity with a null variant. The following publications have been ascertained in the context of this evaluation (PMID: 17458871, 18248830, 25190157). ClinVar contains an entry for this variant (Variation ID: 2203661). Based on the evidence outlined above, the variant was classified as pathogenic. -
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Thr442 amino acid residue in ARSB. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17458871, 25190157; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSB protein function. This missense change has been observed in individual(s) with mucopolysaccharidosis type VI (PMID: 17458871). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 442 of the ARSB protein (p.Thr442Arg). -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at